11035276

Source:http://linkedlifedata.com/resource/pubmed/id/11035276

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003250, umls-concept:C0038250, umls-concept:C0039194, umls-concept:C0333668, umls-concept:C0596545, umls-concept:C1515895, umls-concept:C1527362
pubmed:issue	2
pubmed:dateCreated	2002-1-11
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9001514
pubmed:citationSubset	T
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/CD52 antigen, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0955-3886
pubmed:author	pubmed-author:BunjesDD
pubmed:issnType	Print
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	151-62
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:11035276-Acute Disease, pubmed-meshheading:11035276-Antibodies, Monoclonal, pubmed-meshheading:11035276-Antibodies, Monoclonal, Humanized, pubmed-meshheading:11035276-Antibodies, Neoplasm, pubmed-meshheading:11035276-Antigens, CD, pubmed-meshheading:11035276-Antigens, Neoplasm, pubmed-meshheading:11035276-Bone Marrow Transplantation, pubmed-meshheading:11035276-Clinical Trials as Topic, pubmed-meshheading:11035276-Glycoproteins, pubmed-meshheading:11035276-Graft Rejection, pubmed-meshheading:11035276-Graft Survival, pubmed-meshheading:11035276-Graft vs Host Disease, pubmed-meshheading:11035276-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11035276-Humans, pubmed-meshheading:11035276-Incidence, pubmed-meshheading:11035276-Leukemia, pubmed-meshheading:11035276-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:11035276-Lymphocyte Depletion, pubmed-meshheading:11035276-Recurrence, pubmed-meshheading:11035276-Remission Induction, pubmed-meshheading:11035276-Retrospective Studies, pubmed-meshheading:11035276-Safety, pubmed-meshheading:11035276-Salvage Therapy, pubmed-meshheading:11035276-T-Lymphocytes, Cytotoxic, pubmed-meshheading:11035276-Transplantation, Homologous, pubmed-meshheading:11035276-Transplantation Conditioning, pubmed-meshheading:11035276-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999.
pubmed:affiliation	Stem Cell Transplantation Programme, Department of Haematology/Oncology, Ulm University Hospital, Robert-Koch-Strasse 8, 89081, Ulm, Germany. donald.bunjes@medizin.uni-ulm.de
pubmed:publicationType	Journal Article, Comparative Study, Review